Cardiovascular involvement in systemic autoimmune diseases

Autoimmunity Reviews

Volumn 8, Issue 4, 2009, Pages 281-286

  Sitia, Simona ^a   Atzeni, Fabiola ^b   Sarzi Puttini, Piercarlo ^b   Di Bello, Vitantonio ^c   Tomasoni, Livio ^a   Delfino, Luigi ^a   Antonini Canterin, Francesco ^c   Di Salvo, Giovanni ^c   De Gennaro Colonna, Vito ^a   La Carrubba, Salvatore ^c   Carerj, Scipione ^c   Turiel, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c On behalf of the Italian Society   (Italy)

Author keywords

Coronary angiography; Microcirculation abnormalities; Non invasive diagnostic tools; Systemic autoimmune diseases

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; EZETIMIBE; IMMUNOSUPPRESSIVE AGENT; N(G),N(G) DIMETHYLARGININE; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANGIOCARDIOGRAPHY; ANTIINFLAMMATORY ACTIVITY; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE DURATION; DOPPLER FLOWMETRY; ENDOTHELIAL DYSFUNCTION; GOLD STANDARD; HEART INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MICROANGIOPATHY; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; REVIEW; RHEUMATOID ARTHRITIS; STRESS ECHOCARDIOGRAPHY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TISSUE DOPPLER IMAGING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; HUMANS; RISK ASSESSMENT;

EID: 61349135624     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.08.004     Document Type: Review

References (40)

1. Knonkaert D.C. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28 (2007) 1797-1804
2. Soltész P., Szekanecz Z., Kiss E., and Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev 6 (2007) 379-386
3. Del Rincon I., Williams K., Stern M.P., Freeman G.L., and Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44 (2001) 2737-2745
4. Hahn B.H., Grossman J., Chen W., and McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 28 (2007) 69-75
5. Wolfe F., Rasker J.J., Boers M., Wells G.A., and Michaud K. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Arthritis Rheum 57 (2007) 935-942
6. Rav-Acha M., Plot L., Peled N., and Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev 6 (2007) 566-571
7. Sattar N., McCarey D.W., Capell H., and McInnes I.B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108 (2003) 2957-2963
8. Bassi N., Ghirardello A., Iaccarino L., Zampieri S., Rampudda M.E., Atzeni F., et al. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients. Autoimmun Rev 7 (2007) 52-58
9. Staub H.L., Franck M., Ranzolin A., Norman G.L., Iverson G.M., and von Mühlen C.A. IgA antibodies to beta2-glycoprotein I and atherosclerosis. Autoimmun Rev 6 (2006) 104-106
10. Arosio E., De Marchi S., Rigoni A., Prior M., Delva P., and Lechi A. Forearm hemodynamics, arterial stiffness and microcirculatory reactivity in RA. J Hypertens 25 (2007) 1273-1278
11. Kiani A.N., Mahoney J.A., and Petri M. Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in Systemic Lupus Erythematosus. J Rheumatol 34 (2007) 1502-1505
12. Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106 (2002) 2184-2187
13. Mäki-Petäjä K.M., Booth A.D., Hall F.C., Wallace S.M., Brown J., McEniery C.M., et al. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 50 (2007) 852-858
14. Belizna C.C., Richard V., Thuillez C., Lévesque H., and Shoenfeld Y. Insights into atherosclerosis therapy in antiphospholipid syndrome. Autoimmun Rev 7 (2007) 46-51
15. Rexhepaj N., Bajraktari G., Berisha I., Beqiri A., Shatri F., Hima F., et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Int J Clin Pract 60 (2006) 683-688
16. Caiati C., Zedda N., Montaldo C., Montisci R., and Iliceto S. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a noninvasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 34 (1999) 122-130
17. Hozumi T., Yoshida K., Ogata Y., Asami Y., Ogata Y., Takagi T., et al. Non invasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 97 (1998) 1557-1562
18. Rigo F., Richieri M., Pasanisi E., Cutaia V., Zanella C., Della Valentina P., et al. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 91 (2003) 269-273
19. Dimitrow P.P. Coronary flow reserve-measurement and application: focus on transthoracic Doppler echocardiography (2002), Kluwer Academic Publishers, Boston
20. Rigo F., Gherardi S., Galderisi M., Pratali L., Cortigiani L., Sicari R., et al. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischemic dilated cardiomyopathy. Eur Heart J 27 (2006) 1319-1323
21. Hirata K., Kadirvelu A., Kinjo M., Sciacca R., Sugioka K., Otsuka R., et al. Altered coronary vasomotor function in young patients with Systemic Lupus Erythematosus. Arthritis Rheum 56 (2007) 1904-1909
22. Birdane A., Korkmaz C., Ata N., Cavusoglu Y., Kasifoglu T., Dogan S.M., et al. Tissue doppler imaging in the evaluation of the left and right ventricular diastolic functions in Rheumatoid Arthritis. Echocardiography 24 (2007) 485-493
23. Turiel M., Muzzupappa S., Gottardi B., Crema C., Sarzi-Puttini P., and Rossi E. Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus 9 (2000) 406-412
24. Turiel M., Sarzi-Puttini P., Peretti R., Bonizzato S., Muzzupappa S., Atzeni F., et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol 96 (2005) 574-579
25. Budoff M.J., Georgiou D., Brody A., Agatston A.S., Kennedy J., Wolfkiel C., et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study. Circulation 93 (1996) 898-904
26. Achenbach S., Moshage W., Ropers D Nossen J., and Daniel W.G. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. NEJM 339 (1998) 1964-1971
27. Chung C.P., Oeser A., Raggi P., Gebretsadik T., Shintani A.K., Sokka T., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
28. Kim W.Y., Danias P.G., Stuber M., Flamm S.D., Plein S., Nagel E., et al. Coronary magnetic resonance angiography for the detection of coronary stenosis. NEJM 345 (2001) 1863-1869
29. Turiel M., Peretti R., Sarzi-Puttini P., Atzeni F., and Doria A. Cardiac imaging techniques in systemic autoimmune disease. Lupus 14 (2005) 727-731
30. Sidhu P.S., and Allen P.L. Ultrasound assessment of internal carotid artery stenosis. Clin Radiol 52 (1997) 654-658
31. Kumeda Y., Inaba M., Goto H Nagata M., Henmi Y., Furumitsu Y., et al. Increased thickness of arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 1489-1497
32. Ciftci O., Yilmaz S., Topcu S., Caliskan M., Gullu H., Erdogan D., et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 198 (2008) 332-337
33. Böger R.H., Bode-Böger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98 (1998) 1842-1847
34. Lundman P., Eriksson M.J., Stuhlinger M Cooke J.P., Hamsten A., and Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 38 (2001) 111-116
35. Boger R.H., Bode-Boger S.M., Thiele W Junker W., Alexander K., and Frölich J.C. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95 (1997) 2068-2074
36. Surdacki A., Nowicki M., Sandmann J Tsikas D., Boeger R.H., Bode-Boeger S.M., et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33 (1999) 652-658
37. Stuhlinger M.C., Abbasi F., Chu J.W., Lamendola C., McLaughlin T.L., Cooke J.P., et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287 (2002) 1420-1426
38. Bae S.W., Stuhlinger M.C., Yoo H.S., Yu K.H., Park H.K., Choi B.Y., et al. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 95 (2005) 729-733
39. MacAllister R.J., Rambausek M.H., Vallance P., Williams D., Hoffmann K.H., and Ritz E. Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11 (1996) 2449-2452
40. Surdacki A., Martens-Lobenhoffer J., Wloch A., Marewicz E., Rakowski T., Wieczorek-Surdacka E., et al. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56 (2007) 809-819